Diabetes Technology

G6 CGM System Offers Improved Accuracy in Youth and Adults With Diabetes

G6 CGM System Offers Improved Accuracy in Youth and Adults With Diabetes

By

Investigators evaluate the performance of the G6 factory-calibrated continuous glucose monitoring system over 10 days.

FDA Approves FreeStyle Libre 14 Day Flash Glucose Monitoring System

FDA Approves FreeStyle Libre 14 Day Flash Glucose Monitoring System

By

The new Flash Glucose Monitoring System enables patients to wear the sensor for up to 14 days compared with the existing FreeStyle Libre System that was approved for 10-day wear.

Dual-Hormone Artificial Pancreas Reduces Glucose Variability in T1D

Dual-Hormone Artificial Pancreas Reduces Glucose Variability in T1D

By

Investigators conducted a randomized crossover comparison of 2 dual-hormone artificial pancreas systems — one with rapid insulin and amylin, and another with regular insulin and amylin — with a rapid insulin-alone artificial pancreas.

Improved Glycemic Control With Closed-Loop Insulin Delivery System

Improved Glycemic Control With Closed-Loop Insulin Delivery System

By

Researchers conducted a randomized, open-label trial to assess the effect of an automated closed-loop insulin delivery system on glycemic control in hospitalized patients.

Technosphere Inhaled Insulin Improves Glycemic Control in Type 1 Diabetes

Technosphere Inhaled Insulin Improves Glycemic Control in Type 1 Diabetes

By

Patients were randomly assigned to receive insulin aspart or Technosphere inhaled insulin.

MiniMed 670G System Approved for Use in Younger Patients With T1D

MiniMed 670G System Approved for Use in Younger Patients With T1D

By

The MiniMed 670G system measures glucose levels every 5 minutes and automatically adjusts insulin delivery to avoid highs and lows.

Safety and Performance of Omnipod HCL for Children With Type 1 Diabetes

Safety and Performance of Omnipod HCL for Children With Type 1 Diabetes

By

In children with type 1 diabetes, the Omnipod hybrid closed-loop personal model system was safe and performed well.

Pen vs Patch Bolus Insulin Delivery for T2D Using CGM

Pen vs Patch Bolus Insulin Delivery for T2D Using CGM

By

Investigators compared 2 methods of delivering bolus insulin, pen vs patch, using metrics from continuous glucose monitoring.

ITCA 650 Shows Efficacy in Reducing Weight, HbA1c in Type 2 Diabetes

ITCA 650 Shows Efficacy in Reducing Weight, HbA1c in Type 2 Diabetes

By

The ITCA 650, a small titanium osmotic mini-pump, provides a subcutaneous infusion of exenatide over 3 or 6 months.

Continuous Glucose Monitoring Controls Hypoglycemia Better Than Glucometer

Continuous Glucose Monitoring Controls Hypoglycemia Better Than Glucometer

By

Participants completed surveys for fear of hypoglycemia, hypoglycemia unawareness, and problem areas in diabetes questionnaire.

Implantable Continuous Glucose Monitoring Device Safe, Effective for Adolescents

Implantable Continuous Glucose Monitoring Device Safe, Effective for Adolescents

By

The safety assessment included incidence of insertion or procedure-related removal and device-related serious adverse events through 180 after insertion.

First CGM System With Implantable Glucose Sensor Approved

First CGM System With Implantable Glucose Sensor Approved

By

The sensor is coated with a fluorescent chemical which produces a small amount of light when exposed to blood glucose.

FDA Clears Omnipod DASH System for Diabetes Management

FDA Clears Omnipod DASH System for Diabetes Management

By

The Omnipod DASH system consists of a discreet, tubeless, waterproof Pod which is worn on the body, and the Personal Diabetes Manager (PDM), a handheld wireless device used to control the Pod.

Asymptomatic Hypoglycemia Risk With Frequent Hypoglycemia in T1D

Asymptomatic Hypoglycemia Risk With Frequent Hypoglycemia in T1D

By

Investigators recorded hypoglycemic symptoms and monitored blood sugar levels by continuous glucose monitoring for 6 days.

Individuals With Type 1 Diabetes See Improvement With Continuous Glucose Monitoring

Individuals With Type 1 Diabetes See Improvement With Continuous Glucose Monitoring

By

Investigators seek to determine he effects of continuous glucose monitoring on daytime and nocturnal hypoglycemia in patients with type 1 diabetes.

Pharmacists Can Help With Diabetes Management via Telemedicine

Pharmacists Can Help With Diabetes Management via Telemedicine

Telemedicine could provide real-time feedback loop and allow pharmacists to help patients self-manage.

Continuous Glucose Monitoring Cost-Effective in Type 1 Diabetes

Continuous Glucose Monitoring Cost-Effective in Type 1 Diabetes

For adults with type 1 diabetes with suboptimal control despite using multiple insulin injections, continuous glucose monitoring seems cost-effective, with improved glucose control.

Risks and Benefits of FDA "Pre-Cert" Program for Medical Software Devices Examined

Risks and Benefits of FDA "Pre-Cert" Program for Medical Software Devices Examined

By

The FDA Digital Health Software Precertification Program represents a feasible solution to regulate software classified as a medical device.

FDA Approves Unique Device for Diabetic Retinopathy Screening

FDA Approves Unique Device for Diabetic Retinopathy Screening

By

This is the first device authorized for marketing that provides a screening decision without the need for clinician interpretation.

Accuracy of Novel Implantable Continuous Glucose Monitoring Device Assessed

Accuracy of Novel Implantable Continuous Glucose Monitoring Device Assessed

By

Researchers assessed the safety and accuracy of an implantable continuous glucose measurement in adults diagnosed with type 1 and type 2 diabetes.

New 'Smart' CGM System Provides Predictive Alerts to Patients With Diabetes

New 'Smart' CGM System Provides Predictive Alerts to Patients With Diabetes

By

Users also have access to the Company's Sugar.IQ app, which uses IBM's Watson Health platform, to identify glucose patterns based on factors that may affect them (ie, food intake, insulin dosages, daily routines).

Dexcom G6 Integrated Continuous Glucose Monitoring System Gets FDA Approval

Dexcom G6 Integrated Continuous Glucose Monitoring System Gets FDA Approval

By

The FDA reviewed data for the device through the de novo premarket review pathway, a regulatory pathway for novel, low-to-moderate-risk devices that are not substantially equivalent to an already legally marketed device.

Closed-Loop Insulin Delivery Offers Best Outcomes for Pregnant Women With T1D

Closed-Loop Insulin Delivery Offers Best Outcomes for Pregnant Women With T1D

For pregnant women with type 1 diabetes, a closed-loop system is associated with comparable glucose control and significantly less hypoglycemia than sensor-augmented pump therapy.

MiniMed 670G System Improves Glycemic Outcomes in Children With T1D

MiniMed 670G System Improves Glycemic Outcomes in Children With T1D

By

Research findings indicate improved glycemic outcomes in children with T1D using the MiniMed 670G system, similar to those observed for adolescents and adults.

Case for Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes

Case for Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes

By

An increasing number of studies support the use of continuous glucose monitoring in adult patients with T2D, and the observed benefits are likely to extend to youth with T2D.

Preventing Nocturnal Hypoglycemia: Single- vs Dual-Hormone Artificial Pancreas System

Preventing Nocturnal Hypoglycemia: Single- vs Dual-Hormone Artificial Pancreas System

By

Study suggests that single-hormone artificial pancreas systems may be sufficient for overnight control even in a high-risk group of hypoglycemia-unaware participants with documented nocturnal hypoglycemia.

Novel Deep Learning System May Help Identify Diabetic Retinopathy

Novel Deep Learning System May Help Identify Diabetic Retinopathy

A novel deep learning system has high sensitivity and specificity for identifying diabetic retinopathy.

Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined

Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined

By

In this phase 3 study, statistically and clinically meaningful improvements in HbA1c, body weight, and the proportion of patients achieving goal HbA1c <7% (53mmol/mol) were demonstrated with 2 doses of ITCA 650 vs placebo.

New Continuous Glucose Monitoring System Now Available for Medicare Patients

New Continuous Glucose Monitoring System Now Available for Medicare Patients

By

A new continuous glucose monitoring system that allows patients to capture real-time glucose readings without use calibration or routine fingersticks is now available.

New Insulin Pen With Smartphone App, Bolus Advisor Available

New Insulin Pen With Smartphone App, Bolus Advisor Available

By

The system is able to calculate and recommend optimal insulin dose, track the timing of doses, monitor insulin temperature, remind users to take insulin, and create reports for the healthcare provider.

Sign Up for Free e-Newsletters



CME Focus